ACGIX | VIVAX | ACGIX / VIVAX | |
Total Expense Ratio | 0.78 | 0.17 | 459% |
Annual Report Gross Expense Ratio | 0.78 | 0.17 | 459% |
Fund Existence | 79 years | 33 years | - |
Gain YTD | 9.531 | 9.738 | 98% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.12B | 208B | 2% |
Annual Yield % from dividends | 1.08 | 1.97 | 55% |
Returns for 1 year | -0.72 | 4.63 | -16% |
Returns for 3 years | 12.94 | 42.99 | 30% |
Returns for 5 years | 21.29 | 71.78 | 30% |
Returns for 10 years | 2.29 | 129.45 | 2% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HLMNX | 30.41 | 0.06 | +0.20% |
Harding Loevner International Eq Inv | |||
NSVAX | 14.40 | 0.01 | +0.07% |
Columbia Sm Cp Val and Inflection Inst | |||
PZVSX | 13.10 | -0.01 | -0.08% |
Pzena Small Cap Value Investor | |||
MOPAX | 26.38 | -0.07 | -0.26% |
NYLI WMC Small Companies Class A | |||
VGPMX | 18.89 | -0.18 | -0.94% |
Vanguard Global Capital Cycles Investor |